Literature DB >> 22803794

Raltegravir-induced DRESS syndrome.

Pierre Loulergue1, Olivier Mir.   

Abstract

DRESS syndrome (drug reaction with eosinophilia and systemic symptoms) is a life-threatening adverse drug reaction. Raltegravir is an integrase inhibitor used in HIV-1 infection. We report on a patient who developed a DRESS syndrome under raltegravir treatment, which was identified as a probable case of DRESS on the basis of Kardaun and Naranjo scores. The presented case is the first description of a proven raltegravir-induced DRESS syndrome.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803794     DOI: 10.3109/00365548.2012.689850

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

Review 1.  [Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): a review].

Authors:  S Ständer; D Metze; T Luger; T Schwarz
Journal:  Hautarzt       Date:  2013-08       Impact factor: 0.751

2.  Association of the HLA-B*53:01 Allele With Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) Syndrome During Treatment of HIV Infection With Raltegravir.

Authors:  Mark Thomas; Chris Hopkins; Eamon Duffy; Daniel Lee; Pierre Loulergue; Diego Ripamonti; David A Ostrov; Elizabeth Phillips
Journal:  Clin Infect Dis       Date:  2017-05-01       Impact factor: 9.079

Review 3.  Antiviral drug allergy.

Authors:  Brigitte Milpied-Homsi; Ellen M Moran; Elizabeth J Phillips
Journal:  Immunol Allergy Clin North Am       Date:  2014-08       Impact factor: 3.479

4.  Drug reaction with eosinophilia and systemic symptoms related to antiretroviral treatment in human immunodeficiency virus patients.

Authors:  David Brandariz; Alex Smithson; Vanesa Anton-Vazquez
Journal:  Indian J Sex Transm Dis AIDS       Date:  2017 Jul-Dec
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.